SK10322001A3 - Spôsob prípravy imidazo [1,5-a]pyrido[3,2-e]pyrazínov, farmaceutické prostriedky obsahujúce takéto zlúčeniny a spôsob výroby farmaceutického prostriedku - Google Patents
Spôsob prípravy imidazo [1,5-a]pyrido[3,2-e]pyrazínov, farmaceutické prostriedky obsahujúce takéto zlúčeniny a spôsob výroby farmaceutického prostriedku Download PDFInfo
- Publication number
- SK10322001A3 SK10322001A3 SK1032-2001A SK10322001A SK10322001A3 SK 10322001 A3 SK10322001 A3 SK 10322001A3 SK 10322001 A SK10322001 A SK 10322001A SK 10322001 A3 SK10322001 A3 SK 10322001A3
- Authority
- SK
- Slovakia
- Prior art keywords
- alkyl
- formula
- compounds
- aryl
- pyrido
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains three hetero rings
- C07D471/14—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE1999102082 DE19902082A1 (de) | 1999-01-20 | 1999-01-20 | Verwendung von Imidazo[1,5-a]-pyrido[3,2-e]-pyrazinonen als Inhibitoren der Phosphodiesterase 5 zur Therapie von erectiler Dysfunktion und Verfahren zu deren Herstellung |
DE1999161302 DE19961302A1 (de) | 1999-12-18 | 1999-12-18 | Verwendung von Imidazo(1,5-a)-pyrido(3,2-e)-pyrazinonen als duale Inhibitoren der Phosphodiesterase 5 und der Phosphodiesterase 3 zur Therapie der Herzinsuffizienz, von pulmonaler Hypertonie und Gefäßerkrankungen, die mit einer Minderdurchblutung einhergehen |
PCT/EP2000/000260 WO2000043392A2 (de) | 1999-01-20 | 2000-01-14 | Verwendung von imidazo[1,5-a]-pyrido[3,2-e]-pyrazinonen als arzneimittel |
Publications (1)
Publication Number | Publication Date |
---|---|
SK10322001A3 true SK10322001A3 (sk) | 2002-07-02 |
Family
ID=26051406
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SK1032-2001A SK10322001A3 (sk) | 1999-01-20 | 2000-01-14 | Spôsob prípravy imidazo [1,5-a]pyrido[3,2-e]pyrazínov, farmaceutické prostriedky obsahujúce takéto zlúčeniny a spôsob výroby farmaceutického prostriedku |
Country Status (23)
Country | Link |
---|---|
EP (1) | EP1144410A2 (id) |
JP (1) | JP2002535330A (id) |
KR (1) | KR20010101603A (id) |
CN (1) | CN1344268A (id) |
AR (1) | AR022318A1 (id) |
AU (1) | AU2291200A (id) |
BG (1) | BG105714A (id) |
BR (1) | BR0007613A (id) |
CA (1) | CA2296224A1 (id) |
CO (1) | CO5190700A1 (id) |
CZ (1) | CZ20012627A3 (id) |
EA (1) | EA200100792A1 (id) |
EE (1) | EE200100377A (id) |
HU (1) | HUP0105132A3 (id) |
ID (1) | ID29790A (id) |
IL (1) | IL144156A0 (id) |
IS (1) | IS5987A (id) |
LT (1) | LT2001078A (id) |
LV (1) | LV12793B (id) |
NO (1) | NO20013334L (id) |
SK (1) | SK10322001A3 (id) |
TR (1) | TR200102121T2 (id) |
WO (1) | WO2000043392A2 (id) |
Families Citing this family (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6548490B1 (en) * | 1997-10-28 | 2003-04-15 | Vivus, Inc. | Transmucosal administration of phosphodiesterase inhibitors for the treatment of erectile dysfunction |
US6403597B1 (en) | 1997-10-28 | 2002-06-11 | Vivus, Inc. | Administration of phosphodiesterase inhibitors for the treatment of premature ejaculation |
EP1461022A2 (en) * | 2001-12-17 | 2004-09-29 | ALTANA Pharma AG | Use of selective pde5 inhibitors for treating partial and global respiratory failure |
US6916345B2 (en) | 2002-02-12 | 2005-07-12 | L'oreal S.A. | 6-alkoxy-2,3-diaminopyridine couplers for dyeing keratin fibres |
FR2835741B1 (fr) * | 2002-02-12 | 2006-05-05 | Oreal | Nouveaux coupleurs 6-alcoxy-2,3-diaminopyridine utiles pour la teinture des fibres keratiniques |
DE10325813B4 (de) | 2003-06-06 | 2007-12-20 | Universitätsklinikum Freiburg | Prophylaxe und/oder Therapie bei der portalen Hypertonie |
CA2577442A1 (en) * | 2004-08-17 | 2006-03-02 | The Johns Hopkins University | Pde5 inhibitor compositions and methods for treating cardiac indications |
ES2536906T3 (es) * | 2006-12-13 | 2015-05-29 | Aska Pharmaceutical Co., Ltd. | Derivado de quinoxalina |
WO2009070583A1 (en) * | 2007-11-30 | 2009-06-04 | Wyeth | Pyrido[3,2-e]pyrazines, process for preparing the same, and their use as inhibitors of phosphodiesterase 10 |
CA2706866A1 (en) | 2007-11-30 | 2009-06-04 | Biotie Therapies Gmbh | Aryl and heteroaryl fused imidazo[1,5-a]pyrazines as inhibitors of phosphodiesterase 10 |
JP2015531401A (ja) | 2011-10-10 | 2015-11-02 | ハー・ルンドベック・アクチエゼルスカベット | イミダゾピラジノン骨格を有するpde9i |
US9434733B2 (en) | 2012-01-26 | 2016-09-06 | H. Lundbeck A/S | PDE9 inhibitors with imidazo triazinone backbone |
JP5842640B2 (ja) * | 2012-01-31 | 2016-01-13 | 株式会社東洋新薬 | ホスホジエステラーゼ3阻害剤 |
WO2016022825A1 (en) * | 2014-08-07 | 2016-02-11 | Intra-Cellular Therapies, Inc. | Organic compounds |
US10005789B2 (en) | 2014-08-07 | 2018-06-26 | Intra-Cellular Therapies, Inc. | Organic compounds |
TN2017000507A1 (en) | 2015-07-07 | 2019-04-12 | H Lundbeck As | Pde9 inhibitors with imidazo triazinone backbone and imidazo pyrazinone backbone for treatment of peripheral diseases |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5055465A (en) * | 1989-05-31 | 1991-10-08 | Berlex Laboratories, Inc. | Imidazoquinoxalinones, their aza analogs and process for their preparation |
DE19510965A1 (de) * | 1995-03-24 | 1996-09-26 | Asta Medica Ag | Neue Pyrido/3,2-e/pyrazinone mit antiasthmatischer Wirksamkeit und Verfahren zu deren Herstellung |
-
2000
- 2000-01-14 SK SK1032-2001A patent/SK10322001A3/sk unknown
- 2000-01-14 WO PCT/EP2000/000260 patent/WO2000043392A2/de not_active Application Discontinuation
- 2000-01-14 HU HU0105132A patent/HUP0105132A3/hu unknown
- 2000-01-14 KR KR1020017009112A patent/KR20010101603A/ko not_active Application Discontinuation
- 2000-01-14 TR TR2001/02121T patent/TR200102121T2/xx unknown
- 2000-01-14 EE EEP200100377A patent/EE200100377A/xx unknown
- 2000-01-14 EP EP00901561A patent/EP1144410A2/de not_active Withdrawn
- 2000-01-14 IL IL14415600A patent/IL144156A0/xx unknown
- 2000-01-14 JP JP2000594808A patent/JP2002535330A/ja active Pending
- 2000-01-14 EA EA200100792A patent/EA200100792A1/ru unknown
- 2000-01-14 AU AU22912/00A patent/AU2291200A/en not_active Abandoned
- 2000-01-14 BR BR0007613-9A patent/BR0007613A/pt not_active Application Discontinuation
- 2000-01-14 CZ CZ20012627A patent/CZ20012627A3/cs unknown
- 2000-01-14 ID IDW00200101592A patent/ID29790A/id unknown
- 2000-01-14 CN CN00805307A patent/CN1344268A/zh active Pending
- 2000-01-19 AR ARP000100246A patent/AR022318A1/es unknown
- 2000-01-19 CA CA002296224A patent/CA2296224A1/en not_active Abandoned
- 2000-01-19 CO CO00002747A patent/CO5190700A1/es not_active Application Discontinuation
-
2001
- 2001-06-29 IS IS5987A patent/IS5987A/is unknown
- 2001-07-05 NO NO20013334A patent/NO20013334L/no not_active Application Discontinuation
- 2001-07-17 BG BG105714A patent/BG105714A/xx unknown
- 2001-07-19 LV LV010109A patent/LV12793B/lv unknown
- 2001-07-19 LT LT2001078A patent/LT2001078A/xx not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
AR022318A1 (es) | 2002-09-04 |
IS5987A (is) | 2001-06-29 |
WO2000043392A2 (de) | 2000-07-27 |
LT2001078A (en) | 2002-08-26 |
EA200100792A1 (ru) | 2002-10-31 |
AU2291200A (en) | 2000-08-07 |
JP2002535330A (ja) | 2002-10-22 |
CZ20012627A3 (cs) | 2002-01-16 |
CA2296224A1 (en) | 2000-07-20 |
BG105714A (en) | 2002-02-28 |
NO20013334D0 (no) | 2001-07-05 |
ID29790A (id) | 2001-10-11 |
HUP0105132A3 (en) | 2002-12-28 |
NO20013334L (no) | 2001-07-05 |
EP1144410A2 (de) | 2001-10-17 |
IL144156A0 (en) | 2002-05-23 |
WO2000043392A3 (de) | 2000-09-28 |
KR20010101603A (ko) | 2001-11-14 |
LV12793B (lv) | 2002-05-20 |
CN1344268A (zh) | 2002-04-10 |
LV12793A (lv) | 2002-02-20 |
HUP0105132A2 (hu) | 2002-05-29 |
TR200102121T2 (tr) | 2002-01-21 |
EE200100377A (et) | 2002-10-15 |
CO5190700A1 (es) | 2002-08-29 |
BR0007613A (pt) | 2001-10-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US6462047B1 (en) | Carboline derivatives as cGMP phosphodiesterase inhibitors | |
JP3577630B2 (ja) | ***不全治療に効果を持つピラゾロピリミジノン化合物 | |
SK10322001A3 (sk) | Spôsob prípravy imidazo [1,5-a]pyrido[3,2-e]pyrazínov, farmaceutické prostriedky obsahujúce takéto zlúčeniny a spôsob výroby farmaceutického prostriedku | |
US6143757A (en) | Chemical compounds | |
TWI424999B (zh) | 適合作為傑納斯激酶(janus kinase)抑制劑之氮雜吲哚 | |
SK13232002A3 (sk) | Použitie pyrido[3,2-e]-pyrazinónov ako inhibítorov fosfodiesterázy 5 na liečbu erektilnej dysfunkcie | |
IL152873A (en) | Beta-carboline derivatives for use as phosphodiesterase inhibitors | |
SK284039B6 (sk) | Liečivo na znižovanie hladiny lipidov, hladiny triglyceridov alebo hladiny cholesterolu | |
JP4484517B2 (ja) | ホスホジエステラーゼ阻害剤として有用な置換された四環式ピロロキノロン誘導体 | |
CA2388729A1 (en) | Imidazopyridine derivatives as phosphodiesterase vii inhibitors | |
US6800625B2 (en) | Substituted 2,4-dihydro-pyrrolo[3,4-b]quinolin-9-one derivatives useful as phosphodiesterase inhibitors | |
CS153392A3 (en) | Azole derivatives, process of their preparation and a pharmaceuticalcomposition containing said derivatives | |
EP1109814B1 (en) | 5-heterocyclyl pyrazolo 4,3-d]pyrimidin-7-ones for the treatment of male erectile dysfunction | |
JP2012531419A (ja) | Gaba−a受容体修飾物質としての重水素修飾されたトリアゾロピリダジン誘導体 | |
EP0682947A1 (en) | Medicament for therapeutic and prophylactic treatment of diseases caused by smooth muscle cell hyperplasia | |
US6465465B1 (en) | Process for the treatment of erectile dysfunction and product therefor | |
JP2002522388A (ja) | 性機能障害の治療のためのピリジノン | |
MXPA01007380A (en) | Use of imidazo[1,5-a]-pyrido[3,2-e]-pyrazinones as medicaments | |
JP3940290B2 (ja) | 新規化合物 | |
JPH07110860B2 (ja) | 1−(イミダゾ〔1,2−a〕ピリジン−6−イル)−2−プロパノン誘導体 | |
ZA200105719B (en) | Use of imidazo[1,5-A]-pyrido[3,2-E]-pyrazinones as medicaments. | |
KR20020095469A (ko) | 발기부전을 치료하기 위한, 피리도[3,2-e]-피라지논의포스포디에스테라제 5의 억제제로서의 용도 | |
DE19961302A1 (de) | Verwendung von Imidazo(1,5-a)-pyrido(3,2-e)-pyrazinonen als duale Inhibitoren der Phosphodiesterase 5 und der Phosphodiesterase 3 zur Therapie der Herzinsuffizienz, von pulmonaler Hypertonie und Gefäßerkrankungen, die mit einer Minderdurchblutung einhergehen |